FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

FDA overview of a supplemental application for TEPEZZA (teprotumumab) by Horizon Therapeutics USA, Inc.; the submission status is AP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Orbitopathy
• Thyroid Eye Disease

Drugs mentioned

• TEPEZZA (teprotumumab)

Snippet

SUPPL AP for TEPEZZA (TEPROTUMUMAB)